Teva Pharmaceutical Industries Limited (TEVJF)

Market Cap	18.45B
Revenue (ttm)	16.54B
Net Income (ttm)	-1.64B
Shares Out	n/a
EPS (ttm)	-1.45
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	500
Average Volume	424
Open	14.80
Previous Close	n/a
Day's Range	14.80 - 14.80
52-Week Range	8.50 - 20.00
Beta	0.83
RSI	42.67
Earnings Date	May 2, 2025

About TEVJF

Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams. It also develops, manufactures, and sells active pharmaceutical ingredients. In addition, it f...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1901
• Employees: 35,686
• Stock Exchange: OTCMKTS
• Ticker Symbol: TEVJF

Financial Performance

In 2024, TEVJF's revenue was $16.54 billion, an increase of 4.40% compared to the previous year's $15.85 billion. Losses were -$1.64 billion, 193.2% more than in 2023.